AR226-2647 37 Z-47 REV 6-82 <^M> ESTtBl.lRrl& 1603 E. 1.

AR226-2704 26 AR226-2704 TORONTO WORKSHOP MATERIALS September 13-14,2004 Fluorotelomer Alcohol and Fluorotelomer-Based Polym (Bio)degradation Bob Buck DuPont Chemical Solutions Enterprise Wilmington, DE Fluorotelomer-based Polyme Do polymers "degrade" to form fluorotelomer species that can transform, partition, migrate?

FOR DU FONT USE ONLY AR226-2884 Copiei.

FOR DU FONT USE ONLY AR226-2891 Copies Co E.

ee | ARAR6 -- 3234 | || | | | 416 || | | 1502-4D5u1y6:GavSaugbechSriodnyi iTnoRxsicihOneGenero Repoducion alton "TRADE SECRET Study Tie 1:24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations Revision No. 1 Volume 1 of5 AR226 _ 3234 DuRreovnd 3Pa8g5e "TEST GUIDELINES: U.S.

Effects of Fluorotelomer Products on the Bacterial Growth, Degradation of Organ Microbial Population from Activated Sludge of a Domestic Sewage Treatm i N.1.

UnitCode 8308 1/14/99 2:54PM UROBILINOGEN, 48-HOUR, FECES ,SeneraIlnformaton FEE: $122.70 LABORATORY AREA: Porphydn-32/HC25 ANALYTIC TIME: I day DAY(S) TEST SET UP: Monday throughSaturday TIME OF DAY: Continuously LABORATORY HOURS: MAXIMUM LAB TIME: 3 days COMMENTS AND OTHER REJECTION: -cv 6%.

KION GROUP Page 1 KION GROUP do STILL S.p.A.

B 10 - T E S T 1810 FRONTAGE ROAD NORTHBROOK.

Kyocera-AVX Components Corporation Response to ECHA's Public Consultation on PFAS Restriction Proposal 1 INTRODUCTION This submission pertains to the proposal presented by five states: Germany, Denmark, Netherlands, Norway, and Sweden (referred to as 'dossier submitters').

AN INVESTIGATION OF THE EFFECTS OF FLUOROCARBONS FATTY ACID-BINDING PROTEIN.

ARA26 - 3292 45 TRADE SECRET Study Tide F-25509: Repeated Dose Dermal Toxicity 28-Day Study in Male Rats AR 226_ 3293 DuPont 11763 TEST GUIDELINES: US.

ARAR_G 3u6T i --_ 73 000708 .

EFPIA response to the ECHA consultation on the Annex XV restriction report on Per- and polyfluoroalkyl substances (PFAS) - Restriction on the manufacture, placing on the market and use of PFAS Introduction The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the biopharmaceutical industry operating in Europe.

33) Boiling point (acid form) (200C at 101 kPa) , Contains NO CBI j 952 FLUORINE COMPOUNDS, ORGANIC DEC 0 9 2003 20.